Armata Pharmaceuticals, Inc. (ARMP)

Recent Quarterly Results

Source: Company filings

Price Chart

Armata Pharmaceuticals, Inc. (ARMP) stock price: $5.70 (-0.65, -10.24%)

Why Bull

• •Recent insider buying activity suggests those in the know are optimistic about ARMP's future prospects, signaling confidence in the company's direction. Think of it like insiders loading up on Apple before a major product launch.
• •Community sentiment appears to be leaning bullish, with many expressing positive views on ARMP's long-term potential and innovative approach. This mirrors the early days of Tesla, where passionate supporters fueled the stock's rise.
• •The market seems to be perceiving ARMP favorably, recognizing its potential to disrupt its industry. This positive perception can attract more investors and drive demand for the stock.
• •ARMP's recent developments, such as strategic partnerships or product launches, have been well-received, reinforcing the bullish narrative. It's like when Netflix started producing original content, signaling a shift in the media landscape.

Why Bear

• •Despite some positive sentiment, there's a segment of the community expressing concerns about ARMP's ability to execute its ambitious plans. This skepticism is reminiscent of doubts surrounding WeWork's business model before its downfall.
• •Recent market volatility and broader economic uncertainties could negatively impact ARMP, especially if investor risk appetite diminishes. The 2008 financial crisis showed how quickly market sentiment can shift.
• •Increased competition in ARMP's sector could erode its market share and profitability, leading to investor disappointment. This is similar to how numerous competitors challenged BlackBerry's dominance in the smartphone market.
• •Some community members are questioning the sustainability of ARMP's current growth rate, suggesting it may be overvalued. This echoes concerns about the dot-com bubble, where many companies were valued based on potential rather than actual earnings.

• 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
  benzinga · Feb 3, 2026

Rationale

AI-generated technical analysis for ARMP including trend direction, momentum, and pattern recognition.

What to Watch

Key support and resistance levels, volume signals, and upcoming events.

Risk Management

Position sizing, stop-loss levels, and risk-reward assessment.

Set your price target for Armata Pharmaceuticals, Inc. (ARMP), choose a timeframe, and track your prediction accuracy.

Current price: $5.70 · Analyst target: $9.00

No insider trades in the last 30 days.

Score Factors

• Revenue Growth 4/100

  Revenue grew only 14.2% YoY, suggesting the company is in a slower growth phase.

• Gross Margin 5/100

  Gross margin data is currently unavailable for this company.

• Operating Leverage 4/100

  Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.

• Cash Runway 5/100

  Limited cash of $9M could constrain flexibility; watch for dilution risk or debt issuance.

• R&D Intensity 10/100

  Investing 665.4% of revenue in R&D signals heavy commitment to innovation and future product pipeline.

• Insider Activity 6/100

  No significant insider buying or selling recently, which is neutral for the stock outlook.

• Short Interest 7/100

  Lower turnover at 0.38% means fewer daily trades, which may widen bid-ask spreads.

• Price Momentum 6/100

  Mixed technical signals (above sma50, above sma200); price trend is inconclusive and may consolidate.

• News Sentiment 5/100

  No sentiment data available

What does this score mean?

The MoonshotScore rates ARMP's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Is ARMP a good stock to buy?

Whether ARMP is a good investment depends on your financial goals, risk tolerance, and investment horizon. Review the Investment Thesis, SWOT analysis, and Risk sections on this page. Always do your own research and consult a financial advisor before investing.

What is the ARMP MoonshotScore?

MoonshotScore is our proprietary AI-powered rating system that evaluates stocks based on growth potential, financial health, market momentum, and risk factors. It helps investors quickly identify high-potential opportunities. Check the MoonshotScore badge on this page for the current rating.

How often is ARMP data updated?

Stock prices are updated in real-time during market hours (9:30 AM - 4:00 PM ET). Company fundamentals, analyst ratings, and AI insights are refreshed daily. News is updated continuously throughout the day.

What are the growth catalysts for ARMP?

Growth catalysts vary by company and may include new product launches, market expansion, earnings surprises, partnerships, or industry tailwinds. Check the Catalysts section on this page for specific drivers relevant to Armata Pharmaceuticals, Inc..

Who are ARMP's main competitors?

Armata Pharmaceuticals, Inc.'s competitors depend on its industry and market segments. Check the Competitors section on this page for a list of direct competitors and how ARMP compares.

What do analysts say about ARMP?

Analyst ratings and price targets for ARMP are aggregated from multiple sources. Check the Analyst Consensus tab for buy/hold/sell ratings and the current consensus price target.

What is ARMP's market cap?

Market capitalization reflects the total market value of ARMP's outstanding shares. Check the Key Statistics section at the top of this page for the current market cap and other key financial metrics.

How has ARMP stock performed recently?

Check the Chart & Info tab for ARMP's recent price action, including daily, weekly, and monthly performance charts with technical indicators.

What are the risks of investing in ARMP?

Every stock carries risk. Check the Risks and Weaknesses sections on this page for ARMP-specific risk factors. Consider macroeconomic conditions, industry trends, and company-specific challenges.

Are insiders buying or selling ARMP?

Insider activity can signal management confidence. Check the Insider Flow tab for recent insider buys, sells, and exercise transactions for ARMP.

Is ARMP a good stock for beginners?

Armata Pharmaceuticals, Inc. (ARMP) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.

How risky is ARMP for first-time investors?

Every stock carries risk, including Armata Pharmaceuticals, Inc. (ARMP). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like ARMP.

ARMP vs S&P 500: which is better for new investors?

The S&P 500 (SPY) offers broad diversification across 500 large U.S. companies, making it a lower-risk starting point for new investors. Armata Pharmaceuticals, Inc. (ARMP) is a single stock with higher potential upside but also more concentrated risk. Most financial advisors suggest new investors start with index funds like the S&P 500 and gradually add individual stocks like ARMP as they gain experience. Compare ARMP's MoonshotScore and volatility to the broad market before deciding.

What should beginners know before buying ARMP?

Before buying Armata Pharmaceuticals, Inc. (ARMP), beginners should understand: (1) the company's business model and how it makes money (see the Company Overview on this page), (2) its financial health through revenue growth and gross margins (see MoonshotScore Breakdown), (3) what analysts are saying (check the Analyst Consensus tab), and (4) the key risks (see Risk Factors). Start with a small position you are comfortable losing entirely, and consider dollar-cost averaging instead of investing a lump sum.

How much money do I need to start investing in ARMP?

You can start investing in Armata Pharmaceuticals, Inc. (ARMP) with as little as $1 through fractional shares, which most modern brokers offer. There is no minimum investment required. However, financial experts typically recommend only investing money you will not need for at least 3-5 years. Before buying ARMP, make sure you have an emergency fund covering 3-6 months of expenses and no high-interest debt. Check the current ARMP share price at the top of this page.